Related Experiment Video
Updated: Sep 24, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Urinary Albumin-to-Creatinine Ratio and Risk of Incident Cardiovascular Disease in the KoGES-ARIRANG Community-Based
Minjeong Ko1,2, Yong Whi Jeong3,4, Jang Young Kim5
1Department of Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
Purpose:
We aimed to assess whether low-grade albuminuria, characterized by a low urinary albumin-to-creatinine ratio (UACR) within the normal range (<30 mg/g), could predict cardiovascular disease (CVD) risk in a low-risk general population, with an emphasis on sex- and menopause-specific differences.
Materials And Methods:
We analyzed data from 1327 participants from the Korean Genome and Epidemiology Study, excluding individuals with known CVD or major chronic illnesses, who were followed up for a median of 6.37 years. The UACR was measured from spot urine samples and treated as a continuous variable. The cardiovascular outcomes included stroke, myocardial infarction, and angina. Cox proportional hazards models and restricted cubic spline analyses were used to assess the association between UACR and incident CVD, stratified by sex and menopausal status.
Results:
No significant association was observed between UACR and CVD in men or premenopausal women. However, in postmenopausal women, UACR was significantly associated with incident CVD (adjusted hazard ratio 1.09; 95% confidence interval: 1.01-1.18 per 1 mg/g increase). Spline analyses revealed a clear dose-response relationship in postmenopausal women, whereas no such pattern was observed in the other subgroups. Covariate-stratified analyses suggested a potential interaction effect of body mass index, blood pressure, and lipid profile.
Conclusion:
Low-grade albuminuria may serve as an early biomarker of cardiovascular risk in otherwise healthy individuals, particularly in subgroups susceptible to hormonal or metabolic changes. Routine UACR screening may be a practical tool for early risk stratification and prevention of CVD.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Diabetic Nephropathy